胶质母细胞瘤瘤周脑区差异基因表达:SERPINA3 促进侵袭、干性及放疗抵抗并与不良预后和复发相关
该研究旨在分子层面刻画胶质母细胞瘤瘤周脑区(PBZ)以理解复发机制。在 37 例 GBM 和 22 例对照样本中验证了 8 个差异基因的表达,并聚焦 SERPINA3 进行体外敲低及蛋白表达分析。结果显示 SERPINA3 敲低降低胶质瘤细胞增殖、侵袭、迁移、间质转化、干性和放疗抵抗;其蛋白在 PBZ 高于肿瘤核心,在老年、IDH 野生型和复发肿瘤中更高,且与不良预后正相关。
要点
- SERPINA3 在瘤周脑区表达高于肿瘤核心,并与复发和不良预后相关。
- 体外敲低 SERPINA3 可抑制胶质瘤细胞侵袭、干性及放疗抵抗。
- SERPINA3 或为靶向瘤周侵袭和复发的潜在分子标志物。
核心结论
- SERPINA3 通过调控体外促瘤作用促进 GBM 侵袭性表型,并与不良临床结局相关。
研究设计与样本
- 基于既往肿瘤核心与 PBZ 转录组研究筛选 8 个差异基因,在 GBM(肿瘤核心和 PBZ,n=37)和对照(n=22)样本中行 qPCR 验证。
- 对 SERPINA3 在胶质瘤细胞中行基因敲低进行体外功能表征,并用免疫组化分析其蛋白表达与临床标志物、预后和复发的相关性。
主要发现
- 所选基因的 mRNA 表达在肿瘤核心和 PBZ 中得到验证,且与公共数据库一致。
- SERPINA3 敲低体外显示肿瘤细胞增殖、侵袭、迁移、间质表型转化、干性和放疗抵抗均降低。
- SERPINA3 蛋白在 PBZ 高于肿瘤核心,在老年患者、IDH 野生型和复发肿瘤中更高。
- SERPINA3 表达与患者不良预后呈正相关。
临床怎么用
- SERPINA3 高表达提示 GBM 侵袭、干性及放疗抵抗风险,或有助于识别复发高危患者。
- SERPINA3 可作为潜在治疗靶点,但需进一步临床前和临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Glioblastoma (GBM) is a highly invasive tumor. Despite advances in treatment modalities, tumor recurrence is common, seen mainly in the peritumoral brain zone (PBZ). We aimed to molecularly characterize PBZ, to understand the pathobiology of tumor recurrence. METHODS/PATIENTS: We selected eight differentially regulated genes from our previous transcriptome profiling study on tumor core and PBZ. Expression of selected genes were validated in GBM (tumor core and PBZ, n = 37) and control (n = 22) samples by real time quantitative polymerase chain reaction (qPCR). Serine protease inhibitor clade A, member 3 (SERPINA3) was selected for further functional characterization in vitro by gene knockdown approach in glioma cells. Its protein expression by immunohistochemistry (IHC) was correlated with other clinically relevant GBM markers, patient prognosis and tumor recurrence. RESULTS: The mRNA expression of selected genes from the microarray data validated in tumor core and PBZ and was similar to publicly available databases. SERPINA3 knock down in vitro showed decreased tumor cell proliferation, invasion, migration, transition to mesenchymal phenotype, stemness and radioresistance. SERPINA3 protein expression was higher in PBZ compared to tumor core and also was higher in older patients, IDH wild type and recurrent tumors. Finally, its expression showed positive correlation with poor patient prognosis. CONCLUSIONS: SERPINA3 expression contributes to aggressive GBM phenotype by regulating pro-tumorigenic actions in vitro and is associated with adverse clinical outcome.
引用
- Nimbalkar VP, Kruthika BS, Sravya P, et al. Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence. J Neurooncol. 2021. PMID: 33389566. doi:10.1007/s11060-020-03685-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。